$66.98
al cierre: Nov 4 EDT
$73.76
6.7810.12%
Pre-comercialización: 5:56 AM EDT
Comments
Loading...
Orientación y previsiones
Exact Sciences emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/03/2025 | EXAS | Exact Sciences | FY | 2025 | — | — | — | $3.22B | $3.23B | $3.16B | |
08/06/2025 | EXAS | Exact Sciences | FY | 2025 | — | — | — | $3.13B | $3.17B | $3.10B | |
05/01/2025 | EXAS | Exact Sciences | FY | 2025 | — | — | — | $3.07B | $3.12B | $3.06B | |
02/19/2025 | EXAS | Exact Sciences | FY | 2025 | — | — | — | $3.02B | $3.08B | $3.06B | |
01/12/2025 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.76B | $2.76B | $2.74B | |
01/12/2025 | EXAS | Exact Sciences | Q4 | 2024 | — | — | — | $713.00M | $713.00M | $694.76M | |
11/05/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.73B | $2.75B | $2.83B | |
07/31/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.81B | $2.85B | $2.83B | |
06/03/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.81B | $2.85B | $2.83B | |
06/03/2024 | EXAS | Exact Sciences | Q2 | 2024 | — | — | — | $677.00M | $697.00M | $690.49M | |
05/08/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.81B | $2.85B | $2.83B | |
02/21/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.81B | $2.85B | $2.83B | |
01/07/2024 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.50B | $2.50B | $2.48B | |
01/07/2024 | EXAS | Exact Sciences | FY | 2024 | — | — | — | $2.83B | $2.83B | $2.83B | |
01/07/2024 | EXAS | Exact Sciences | Q4 | 2023 | — | — | — | $645.50M | $647.50M | $631.52M | |
11/01/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.48B | $2.49B | $2.46B | |
08/01/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.44B | $2.47B | $2.42B | |
06/21/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.40B | $2.40B | $2.42B | |
05/09/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.38B | $2.42B | $2.30B | |
02/21/2023 | EXAS | Exact Sciences | FY | 2023 | — | — | — | $2.27B | $2.31B | $2.29B | |
01/08/2023 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $2.08B | $2.08B | $2.03B | |
01/08/2023 | EXAS | Exact Sciences | Q4 | 2022 | — | — | — | $550.70M | $552.70M | $506.48M | |
11/03/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $2.02B | $2.04B | $2.01B | |
08/02/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $1.98B | $2.02B | $2.02B | |
04/26/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $1.99B | $2.03B | $2.01B | |
02/22/2022 | EXAS | Exact Sciences | FY | 2022 | — | — | — | $1.98B | $2.03B | $1.99B | |
01/09/2022 | EXAS | Exact Sciences | Q4 | 2021 | — | — | — | $472.00M | $475.00M | $440.30M | |
01/09/2022 | EXAS | Exact Sciences | FY | 2021 | — | — | — | $1.76B | $1.77B | $1.73B | |
11/02/2021 | EXAS | Exact Sciences | FY | 2021 | — | — | — | $1.72B | $1.74B | $1.73B | |
07/28/2021 | EXAS | Exact Sciences | FY | 2021 | — | — | — | $1.71B | $1.75B | $1.72B | |
05/04/2021 | EXAS | Exact Sciences | FY | 2021 | — | — | — | $1.69B | $1.74B | $1.72B |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de Exact Sciences (EXAS)?
En los últimos meses no se han comunicado orientaciones específicas de ventas o beneficios para Exact Sciences.
Explora orientación y previsión sobre todos los valores.